Home › Funds › ArrowMark Colorado Holdings LLC › BMRN
ArrowMark Colorado Holdings LLC position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
ArrowMark Colorado Holdings LLC reported holding 193,000 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$11.6M, representing 0.55% of its reported portfolio and ranking #47 among its reported holdings. ArrowMark Colorado Holdings LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ArrowMark Colorado Holdings LLC's BMRN position evolved
ArrowMark Colorado Holdings LLC first disclosed a stake in BMRN in Q3 2026 at 193,000 shares (US$11.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 193.00K | $11.58M | New |
About BMRN and 13F data
BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMRN
- PRIMECAP MANAGEMENT CO/CA/ 14.99M sh · $899.34M · Q3 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.62M sh · $435.82M · Q2 2026
- Deep Track Capital, LP 6.37M sh · $382.46M · Q3 2026
- Vestal Point Capital, LP 6.03M sh · $344.75M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M sh · $108.89M · Q2 2026
More on ArrowMark Colorado Holdings LLC
FAQ
How long has ArrowMark Colorado Holdings LLC held BMRN?
ArrowMark Colorado Holdings LLC has disclosed BMRN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ArrowMark Colorado Holdings LLC's current position in BMRN?
As of Q3 2026, ArrowMark Colorado Holdings LLC holds 193.00K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $11.58M, representing 0.55% of its reported portfolio and ranking #47.
Has ArrowMark Colorado Holdings LLC been buying or selling BMRN?
In the latest 13F filing (Q3 2026), ArrowMark Colorado Holdings LLC newly opened its position in BMRN.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.